Schülke & Mayr GmbH

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40015939

Informations générales

Localisation

Germany

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

23/11/2023

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Schülke & Mayr GmbH commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year. Schülke & Mayr GmbH also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 25% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

5299006GY9BTDUJWSB95

Source : Science Based Targets initiative | Données publiques